choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Namenda

Namenda Newsletter
  • Alzheimer's conference discusses new treatments 28 Dec 2024 11:21 GMT

    pharmaceutical developments for the disease. According to Phipps, the drugsdrug called Memantine but also known by the brand name Namenda … those symptoms begin. Typical medications for Alzheimer’s are … drugs that you’ll hopefully be able to take in pill

  • Treatment Advances for Alzheimer Disease Provide Hope 20 Dec 2024 17:01 GMT

    … RPh, earned her doctoral degree from the University … CLARITY AD (NCT03887455) trial, investigators are evaluating the … nerve cells.2 Memantine (Namenda; Allergan) is a … information about treatments, adverse effects, and medication adherence. Pharmacists …

  • FTC v Actavis and pricing practices spearhead rise in US pharmaceutical antitrust cases 12 Aug 2024 10:51 GMT

    trials both concerned the same product, Opana. The first Opana trialNamenda and Doryx Namenda and Doryx were the first cases to address pharmaceutical … older HIV treatments to newer treatments.[93] … allegations that the Medicare Drug Price Negotiation …

  • Namenda interactions: Alcohol, medications, and other factors 07 Jun 2024 18:58 GMT

    … OTC cough remedies before using them with Namenda, or … foods during Namenda treatment, talk with your doctor. Namenda and vaccines … medication interacting with lab tests, talk with your doctor. NAMENDA … enough clinical trials to determine whether Namenda is safe …

  • Top Treatment Prospects: Alzheimer’s Disease 20 May 2024 14:12 GMT

    … , CEO at NKGen Biotech. Chris Ward, CSO … trials for drugs targeting beta-amyloid have prompted drugtreatments and drugs targeting the various aging pathways, culminating in a personalized medicine … of information among pharmaceutical companies, non-profit …

  • Alzheimer’s Disease and Current Treatment 16 Jun 2023 17:24 GMT

    … process. In ongoing clinical trials, scientists are looking at … 6,11 The fourth drug, memantine (Namenda), is an N-methyl … medications have not shown meaningful patient benefit.3 The FDA … Kennelly SP, O’Neill D. Drug treatments in Alzheimer’s disease. Clin …

  • Does Medicare pay for Alzheimer’s drugs? The answer is complicated and changing 15 Jun 2023 18:29 GMT

    … know. Medicare and Alzheimer’s drugs There are no drugs or treatments to … mild to moderate disease. Namenda and Namzaric are approved for … who also have a doctor participating in a special … s. A clinical trial showed this drug slowed Alzheimer’s progression …

  • Whistleblower suit against Allergan over dementia drug tossed 14 Mar 2023 01:13 GMT

    … invalid pharmaceutical patents that brand manufacturers use to protect their drugs from … lower-priced generic alternatives for Namenda XR and Namzaric, allowing defendants … Johnson & Johnson and Valiant Pharmaceuticals. In 2020, one of his …

  • Miller Law LLC and Safirstein Law LLC Announce Proposed Settlements in the Namenda Indirect Purchaser Antitrust Litigation 01 Dec 2022 21:57 GMT

    … the Alzheimer’s Disease Drug Namenda XR or Namenda IR and its … Laboratories, Inc., Teva Pharmaceutical Industries, Ltd., and Teva Pharmaceuticals USA, Inc. ( … (jointly, “Wockhardt”); Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., and Upsher …

  • Alzheimer’s Pipeline Drug Market Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2027 22 Mar 2022 10:30 GMT

    medicines that have been approved by the FDA for the treatment … the Alzheimer’s Pipeline Drug market. Leading Companies … Tons, 2017–2027) Namenda Ebixa Axura Aricept Nootropil … personalized medicine, and increasing number of clinical trials for …

Satisfied with the content?

Continue to create your account.